Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.63 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.50 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.47 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.47 |
| ▸ | GABRP | O00591 | 1/20 | 0.45 |
| ▸ | GABRD | O14764 | 1/20 | 0.45 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.45 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.45 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.45 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.45 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.45 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.45 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.45 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19929774 | 0.89 | TAAR1 (0.52) | TAAR1ESR2ALDH1A1MAPK1CYP11B2 | |
| SCHEMBL9292507 | 0.84 | TAAR1 (0.54) | TAAR1ESR2CYP11B2CYP17A1CYP3A4 | |
| SCHEMBL15605009 | 0.83 | TAAR1 (0.71) | TAAR1ESR2ALDH1A1CYP11B2CYP17A1 | |
| SCHEMBL777750 | 0.83 | TAAR1 (0.71) | TAAR1ESR2CYP11B2CYP17A1CYP3A4 | |
| SCHEMBL12619988 | 0.83 | ALDH1A1 (0.68) | ALDH1A1MAPK1CYP11B2CYP3A4CYP11B1 | |
| SCHEMBL3946608 | 0.83 | ALDH1A1 (0.68) | ALDH1A1MAPK1CYP11B2CYP3A4CYP11B1 | |
| SCHEMBL851174 | 0.83 | TAAR1 (0.53) | TAAR1ESR2CYP11B2CYP17A1CYP3A4 | |
| SCHEMBL198702 | 0.83 | TAAR1 (0.68) | TAAR1ESR2CYP11B2CYP17A1CYP3A4 | |
| SCHEMBL7796200 | 0.81 | TAAR1 (0.50) | TAAR1ESR2ALDH1A1MAPK1CYP11B2 | |
| Biphenyl SCHEMBL25183774 | 0.80 | TAAR1 (0.67) | TAAR1ESR2ALDH1A1CYP11B2CYP17A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110790641-B | Method for producing compound having oxydifluoromethylene skeleton | 大金工业株式会社 | 2023-02-28 | — | — | CN | disclosed |
| US-11588115-B2 | Nitrogen-containing compound, organic electroluminescent device and electronic apparatus | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-02-21 | — | — | US | disclosed |
| CN-113234036-A | NMDA receptor antagonists and uses thereof | 中国科学院上海有机化学研究所 | 2021-08-10 | — | — | CN | disclosed |
| WO-2021135181-A1 | NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE AND ELECTRONIC DEVICE | 陕西莱特光电材料股份有限公司 | 2021-07-08 | — | — | WO | disclosed |
| CN-106132915-B | Method for producing compound having oxydifluoromethylene skeleton | 大金工业株式会社 | 2020-03-31 | — | — | CN | disclosed |
| CN-110790641-A | Method for producing compound having oxydifluoromethylene skeleton | 大金工业株式会社 | 2020-02-14 | — | — | CN | disclosed |
| EP-2842974-B1 | COMPOUND HAVING FOUR POLYMERIZABLE GROUPS, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC CORP (JP) | 2019-03-13 | — | — | EP | disclosed |
| EP-3199558-A1 | COMPOUND HAVING FOUR POLYMERIZABLE GROUPS, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC Corporation (JP) | 2017-08-02 | — | — | EP | disclosed |
| EP-3121160-A1 | METHOD FOR PRODUCING COMPOUND HAVING OXYDIFLUOROMETHYLENE SKELETON | Daikin Industries, Ltd. (JP) | 2017-01-25 | — | — | EP | disclosed |
| EP-2842974-A1 | COMPOUND HAVING FOUR POLYMERIZABLE GROUPS, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC Corporation (JP) | 2015-03-04 | — | — | EP | disclosed |
| CN-102256969-A | Compounds that modulate intracellular calcium | CALCIMEDICA INC | 2011-11-23 | — | — | CN | disclosed |
| US-20110112103-A1 | 5-HYDROXYPYRIMIDINE-4-CARBOXAMIDE COMPOUND | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2011-05-12 | — | — | US | disclosed |
| EP-0637623-B1 | Cyclic hydrocarbon derivative and liquid crystal composition containing the same | DAINIPPON INK & CHEMICALS (JP) | 2001-10-04 | — | — | EP | disclosed |
| EP-0893424-A1 | ALPHA,ALPHA-DIFLUOROBENZYL ETHER DERIVATIVES, LIQUID CRYSTAL COMPOSITIONS, AND LIQUID CRYSTAL DISPLAY DEVICES | CHISSO CORPORATION (JP) | 1999-01-27 | — | — | EP | disclosed |
| US-5536443-A | DUTERIUM CONTAINING COMPOUNDS FOOR ELECTROOPTICAL APPARATUS | DAINIPPON INK & CHEMICALS, INC. (JP) | 1996-07-16 | — | — | US | disclosed |
| US-5474707-A | Electrooptic display | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1995-12-12 | — | — | US | disclosed |
| EP-0637623-A1 | Cyclic hydrocarbon derivative and liquid crystal composition containing the same | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1995-02-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11588115-B2 | Nitrogen-containing compound, organic electroluminescent device and electronic apparatus | NCL, NCLN, NNMT | TAAR1 2366/4885ESR2 901/4885ALDH1A1 3230/4885 |
| US-20110112103-A1 | 5-HYDROXYPYRIMIDINE-4-CARBOXAMIDE COMPOUND | EPOR, CBR1, CBR3 | TAAR1 1789/4885ESR2 93/4885ALDH1A1 1179/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.